Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Poly Medicure Ltd.
Source DateBoard Meeting DateDetails
28-Jul-2025 08-Aug-2025 Quarterly Results
29-Apr-2025 06-May-2025 Final Dividend & Audited Results
27-Jan-2025 03-Feb-2025 Quarterly Results
21-Oct-2024 28-Oct-2024 Employees Stock Option Plan & Quarterly Results
18-Jul-2024 22-Jul-2024 Quarterly Results
25-Jun-2024 29-Jun-2024 Inter alia to consider and finalize the terms and condition and approve the modes of fund raising.
02-May-2024 17-May-2024 Audited Results & Final Dividend
04-Mar-2024 08-Mar-2024 Inter alia, to consider the following:- a) Business Plan for Financial Year 2024-25. b) consider and evaluate a proposal for raising of funds, in one or more tranches, through permissible mode(s) and / or combination(s) thereof as may be considered appropriate, by way of raising of debts, issuance of any instruments or securities, through private placement, preferential issue, rights issue, qualified institutions placement or such other methods or combinations thereof as may be decided by the Board, subject to such approvals as may be required, and to transact other businesses with the permission of the Chairperson.
19-Jan-2024 31-Jan-2024 Quarterly Results
25-Oct-2023 04-Nov-2023 Quarterly Results
26-Jul-2023 07-Aug-2023 Quarterly Results
02-May-2023 09-May-2023 Final Dividend & Audited Results
17-Jan-2023 28-Jan-2023 Quarterly Results
19-Oct-2022 04-Nov-2022 Quarterly Results
25-Jul-2022 04-Aug-2022 Quarterly Results
11-May-2022 24-May-2022 Final Dividend & Audited Results
18-Jan-2022 31-Jan-2022 Quarterly Results
19-Oct-2021 01-Nov-2021 Quarterly Results
14-Jul-2021 29-Jul-2021 Quarterly Results
14-May-2021 24-May-2021 Dividend & Audited Results Iinter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2021. b) To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2021. c) To transact any other matter which the Board may deem fit.
Page 1 of 6
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.